Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Citi
Cantor Fitzgerald
Colorcon
Harvard Business School
Healthtrust
AstraZeneca
Federal Trade Commission
Accenture

Generated: September 18, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,181,963

« Back to Dashboard

Which drugs does patent 6,181,963 protect, and when does it expire?

Patent 6,181,963 protects IONSYS and is included in one NDA.

This patent has twenty-one patent family members in eighteen countries.

Summary for Patent: 6,181,963
Title: Transdermal electrotransport delivery device including a cathodic reservoir containing a compatible antimicrobial agent
Abstract:A transdermal electrotransport drug delivery device having an anode, a cathode and a source of electrical power electrically connected to the anode and the cathode. The cathode includes a cathodic electrode and a cathodic reservoir comprised of a housing composed of a polymeric material and an aqueous medium in contact with the housing. The aqueous medium includes i) a drug or an electrolyte salt or a mixture thereof and ii) a cetylpyridinium salt in an amount sufficient to inhibit microbial growth in the aqueous medium. The polymeric material is compatible with the cetylpyridinium salt. A process is also provided wherein when electric current flows from the source of electrical power so that the drug is transdermally delivered to the patient by electrotransport from the anodic reservoir, the cetylpyridinium salt is not transdermally delivered to the patient by electrotransport from the cathodic reservoir. A process for preparing a transdermal electrotransport drug delivery device is also provided.
Inventor(s): Chin; Ivan W. (Belmont, CA), Murdock; Thomas O. (Vadnais Heights, MN), Cormier; Michel J. N. (Mountain View, CA)
Assignee: Alza Corporation (Mountain View, CA)
Application Number:09/433,615
Patent Claim Types:
see list of patent claims
Compound; Delivery; Device; Process;

Drugs Protected by US Patent 6,181,963

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
The Medicines Co IONSYS fentanyl hydrochloride SYSTEM;IONTOPHORESIS, TRANSDERMAL 021338-001 May 22, 2006 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Family Members for US Patent 6,181,963

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 1332100 ➤ Try a Free Trial
Australia 766913 ➤ Try a Free Trial
Canada 2349715 ➤ Try a Free Trial
China 1170604 ➤ Try a Free Trial
China 1324259 ➤ Try a Free Trial
Cyprus 1107290 ➤ Try a Free Trial
Germany 69937647 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
McKesson
Medtronic
Merck
Fuji
Fish and Richardson
AstraZeneca
Mallinckrodt
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.